首站-论文投稿智能助手
典型文献
Novel SARS-CoV-2 receptors:ASGR1 and KREMEN1
文献摘要:
The interaction of the SARS-CoV-2 spike protein with the cellular receptor ACE2 is believed to be essential for viral entry into host cells.in a recent paper published in Cell Research,Gu and colleagues report that ASGR1 and KREMEN1 can also serve as SARS-CoV-2 receptors and might impact viral target cell range and antibody-mediated neutralization.
文献关键词:
作者姓名:
Markus Hoffmann;Stefan P(o)hlmann
作者机构:
Infection Biology Unit,German Primate Center,G(o)ttingen,Germany;Faculty of Biology and Psychology,Georg-August-University G(o)ttingen,G(o)ttingen,Germany
引用格式:
[1]Markus Hoffmann;Stefan P(o)hlmann-.Novel SARS-CoV-2 receptors:ASGR1 and KREMEN1)[J].细胞研究(英文版),2022(01):1-2
A类:
ASGR1,KREMEN1
B类:
Novel,SARS,CoV,receptors,interaction,spike,protein,cellular,ACE2,believed,essential,viral,entry,into,host,cells,recent,paper,published,Cell,Research,Gu,colleagues,report,that,can,also,serve,as,might,impact,target,range,antibody,mediated,neutralization
AB值:
0.603205
相似文献
SARS-CoV-2 impairs the disassembly of stress granules and promotes ALS-associated amyloid aggregation
Yichen Li;Shuaiyao Lu;Jinge Gu;Wencheng Xia;Shengnan Zhang;Shenqing Zhang;Yan Wang;Chong Zhang;Yunpeng Sun;Jian Lei;Cong Liu;Zhaoming Su;Juntao Yang;Xiaozhong Peng;Dan Li-Bio-X Institutes,Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders,Ministry of Education,Shanghai Jiao Tong University,Shanghai 200030,China;School of Life Sciences and Biotechnology,Shanghai Jiao Tong University,Shanghai 200030,China;National Kunming High-level Biosafety Primate Research Center,Institute of Medical Biology,Chinese Academy of Medical Sciences and Peking Union Medical College,Kunming 650031,China;State Key Laboratory of Medical Molecular Biology,Chinese Academy of Medical Sciences,School of Basic Medicine,Peking Union Medical College,Beijing 100005,China;Interdisciplinary Research Center on Biology and Chemistry,Shanghai Institute of Organic Chemistry,Chinese Academy of Sciences,Shanghai 201210,China;University of Chinese Academy of Sciences,Beijing 100049,China;State Key Laboratory of Biotherapy,Department of Geriatrics and National Clinical Research Center for Geriatrics,West China Hospital,Sichuan University,Chengdu 610041,China;State Key Laboratory of Medical Molecular Biology,Department of Biochemistry and Molecular Biology,Institute of Basic Medical Sciences,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100005,China;Bio-X-Renji Hospital Research Center,Renji Hospital,School of Medicine,Shanghai Jiao Tong University,Shanghai 200240,China;Zhangjiang Institute for Advanced Study,Shanghai Jiao Tong University,Shanghai 200240,China
An ultrapotent pan-β-coronavirus lineage B(β-CoV-B)neutralizing antibody locks the receptor-binding domain in closed conformation by targeting its conserved epitope
Zezhong Liu;Wei Xu;Zhenguo Chen;Wangjun Fu;Wuqiang Zhan;Yidan Gao;Jie Zhou;Yunjiao Zhou;Jianbo Wu;Qian Wang;Xiang Zhang;Aihua Hao;Wei Wu;Qianqian Zhang;Yarning Li;Kaiyue Fan;Ruihong Chen;Qiaochu Jiang;Christian T.Mayer;Till Schoofs;Youhua Xie;Shibo Jiang;Yumei Wen;Zhenghong Yuan;Kang Wang;Lu Lu;Lei Sun;Qiao Wang-Key Laboratory of Medical Molecular Virology(MOE/NHC/CAMS),School of Basic Medical Sciences;Shanghai Institute of Infectious Disease and Biosecurity;the Fifth People's Hospital of Shanghai;Shanghai Key Laboratory of Medical Epigenetics,International Co-laboratory of Medical Epigenetics and Metabolism(Ministry of Science and Technology);Institutes of Biomedical Sciences;Biosafety Level 3 Laboratory,Shanghai Medical College,Fudan University,Shanghai 200032,China;CAS Key Laboratory of Infection and Immunity,National Laboratory of Macromolecules,Institute of Biophysics,Chinese Academy of Sciences,Beijing 100101,China;Experimental Immunology Branch,Center for Cancer Research,National Cancer Institute,National Institutes of Health,Bethesda,MD 20892,USA;GSK Vaccines,1300 Wavre,Belgium
Rapid screening of SARS-CoV-2 inhibitors via ratiometric fluorescence of RBD—ACE2 complexes in living cells by competitive binding
Lu Miao;Wei Zhou;Chunyu Yan;Yuebin Zhang;Qinglong Qiao;Xuelian Zhou;Yingzhu Chen;Guangying Wang;Zhen-dong Guo;Jun Liu;Hailong Piao;Xia Pan;Mengxue Yan;Weijie Zhao;Guohui Li;Yueqing Li;Zhaochao Xu-CAS Key Laboratory of Separation Science for Analytical Chemistry,Dalian Institute of Chemical Physics,Chinese Academy of Sciences,Dalian 116023,China;State Key Laboratory of Molecular Reaction Dynamics,Dalian Institute of Chemical Physics,Chinese Academy of Sciences,Dalian 116023,China;Institute of Military Veterinary Science,The Academy of Military Medical Science of PLA,Changchun 130000,China;State Key Laboratory of Fine Chemicals,Department of Pharmaceutical Sciences,School of Chemical Engineering,Dalian University of Technology,Dalian 116024,China
Comparison of viral propagation and drug response among SARS-CoV-2 VOCs using replicons capable of recapitulating virion assembly and release
Lingqian Tian;Qiuhong Liu;Rongjuan Pei;Yingshan Chen;Chonghui Xu;Jielin Tang;Hao Sun;Kunpeng Liu;Qi Yang;Lei Yang;Leshan Li;Yongli Zhang;Yuan Zhou;Chao Shan;Xue Hu;Xinwen Chen;Yun Wang-State Key Laboratory of Virology,Wuhan Institute of Virology,Center for Biosafety Mega-Science,Chinese Academy of Sciences,Wuhan,430071,China;University of Chinese Academy of Sciences,Beijing 100049,China;Guangzhou Institutes of Biomedicine and Health,Chinese Academy of Sciences,Guangzhou,510530,China;Department of Gastroenterology,Guangzhou Women and Children's Medical Center,Guangzhou,510623,China;Innovation Center for Pathogen Research,Guangzhou Laboratory,Guangzhou,510320,China
SARS-CoV-2 infection induces testicular injury in Rhesus macaque
Mengying Liang;Wanbo Tai;Yunyun Wang;Yulong Dai;Yanfeng Yao;Juan Min;Yiwu Zhou;Liang Liu;Chao Shan;Han Xia;Zhiming Yuan-Key Laboratory of Special Pathogens and Biosafety,Wuhan Institute of Virology,Chinese Academy of Sciences,Wuhan,430061,China;University of Chinese Academy of Sciences,Beijing 100049,China;Institute of Infectious Diseases,Shenzhen Bay Laboratory,Shenzhen,518069,China;Department of Forensic Medicine,Tongji Medical College of Huazhong University of Science and Technology,Wuhan,430030,China;Wuhan National Biosafety Laboratory,Chinese Academy of Sciences,Wuhan,430073,China;The Core Facility and Technical Support,Wuhan Institute of Virology,Chinese Academy of Sciences,Wuhan,430061,China;State Key Laboratory of Virology,Wuhan Institute of Virology,Chinese Academy of Sciences,Wuhan,430061 China
Structures of SARS-CoV-2 spike protein alert noteworthy sites for the potential approaching variants
Xiaorui Xing;Lei Wang;Zhen Cui;Wangjun Fu;Tao Zheng;Lili Qin;Pingju Ge;Aidong Qian;Nan Wang;Shuai Yuan-College of Veterinary Medicine,Jilin Agricultural University,Changchun,130118,China;College of Animal Science and Technology,Jilin Provincial Engineering Research Center of Animal Probiotics,Key Lab of Animal Production,Product Quality and Security,Joint Laboratory of Modern Agricultural Technology International Cooperation,Ministry of Education,Jilin Agricultural University,Changchun,130118,China;CAS Key Laboratory of Infection and Immunity,National Laboratory of Macromolecules,Institute of Biophysics,Chinese Academy of Sciences,Beijing 100101,China;University of Chinese Academy of Sciences,Beijing 100101,China;Acrobiosystems,Beijing,100101,China;State Key Laboratory of Virology,Wuhan Institute of Virology,Chinese Academy of Sciences,Wuhan,430071,China
Early assessment of the safety and immunogenicity of a third dose(booster)of COVID-19 immunization in Chinese adults
Yuntao Zhang;Yunkai Yang;Niu Qiao;Xuewei Wang;Ling Ding;Xiujuan Zhu;Yu Liang;Zibo Han;Feng Liu;Xinxin Zhang;Xiaoming Yang-China National Biotec Group Company Limited,Beijing 100024,China;Shanghai Institute of Hematology,State Key Laboratory of Medical Genomics,National Research Center for Translational Medicine at Shanghai,Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;Beijing Institute of Biological Products,China National Biotec Group Company Limited,Beijing 100176,China;National Vaccine and Serum Institute,China National Biotec Group Company Limited,Beijing 101111,China;Department of Infectious Diseases,Research Laboratory of Clinical Virology,Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China
Discovery of SARS-CoV-2-E channel inhibitors as antiviral candidates
Yi Wang;Sui Fang;Yan Wu;Xi Cheng;Lei-ke Zhang;Xu-rui Shen;Shuang-qu Li;Jian-rong Xu;Wei-juan Shang;Zhao-bing Gao;Bing-qing Xia-CAS Key Laboratory of Receptor Research,Stake Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;University of Chinese Academy of Sciences,Beijing 100049,China;State Key Laboratory of Virology,Wuhan Institute of Virology,Center for Biosafety Mega-Science,Chinese Academy of Sciences,Wuhan 430071,China;Academy of Integrative Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Department of Pharmacology and Chemical Biology,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;Zhongshan Institute of Drug Discovery,Institution for Drug Discovery Innovation,Chinese Academy of Science,Zhongshan 528400,China
Discovery of potential small molecular SARS-CoV-2 entry blockers targeting the spike protein
Lin Wang;Yan Wu;Sheng Yao;Huan Ge;Ya Zhu;Kun Chen;Wen-zhang Chen;Yi Zhang;Wei Zhu;Hong-yang Wang;Yu Guo;Pei-xiang Ma;Peng-xuan Ren;Xiang-lei Zhang;Hui-qiong Li;Mohammad A.Ali;Wen-qing Xu;Hua-liang Jiang;Lei-ke Zhang;Li-li Zhu;Yang Ye;Wei-juan Shang;Fang Bai-Shanghai Institute for Advanced Immunochemical Studies,ShanghaiTech University,Shanghai 201210,China;School of Life Science and Technology,ShanghaiTech University,Shanghai 201210,China;State Key Laboratory of Virology,Wuhan Institute of Virology,Center for Biosafety Mega-Science,Chinese Academy of Sciences,Wuhan 430064,China;Department of Natural Products Chemistry,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;State Key Laboratory of Bioreactor Engineering,Shanghai Key Laboratory of New Drug Design,School of Pharmacy,East China University of Science and Technology,Shanghai 200237,China;CAS Key Laboratory of Receptor Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;College of Pharmacy and State Key Laboratory of Medicinal Chemical Biology,Nankai University,Tianjin 300071,China;Department of Botany and Microbiology,College of Science,King Saud University,Riyadh,Saudi Arabia
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。